Expand chart
Data: CMS; Chart: Harry Stevens/Axios

Taxpayers are picking up more and more of the tab for Medicare's prescription drug coverage, because more seniors are racking up bills big enough to enter the program's "catastrophic phase," where government subsides are the highest.

Between the lines: Some experts say the program's basic structure encourages this spending growth, and needs to be reformed.

How it works: Medicare Part D has a ridiculously complicated financing structure, with different parties responsible for varying portions of each patient's bill throughout the year.

  • Insurers pay a large portion of seniors' initial drug costs.
  • But once patients spend a certain amount, they enter the catastrophic phase. Then the government pays 80% of the costs, through a reinsurance program. The insurer pays 15% and the enrollee pays 5%.
  • Higher reinsurance spending is driven by the number of enrollees who reach the catastrophic phase, and the costs they each incur.

Why it matters: As drug prices rise, patients and taxpayers are both paying more.

What they're saying: "The insurer is basically off the hook" once patients reach the catastrophic phase, said Doug Holtz-Eakin of the American Action Forum.

  • “The insurance guys don’t have strong incentives to negotiate too hard and pharma has every incentive to have high prices," Holtz-Eakin added.
  • "For products with exceptionally high prices, ...[insurers] are largely shielded from the costs of most price increases — effectively limiting the ability of the market to lower these drug prices," Northwestern's Craig Garthwaite said in a recent congressional testimony.

Yes, but: There's no government-funded safety net in private insurance, but even in that market, insurers aren't always able to negotiate lower prices.

  • Even in a restructured Part D program, insurers still might struggle to get lower prices for drugs that have no competition, or that Medicare requires them to cover.
  • "We should increase their incentive to negotiate, but we also need to be realistic about how much they can negotiate for those products," Vanderbilt's Stacie Dusetzina said.

Go deeper

Updated 56 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Eniola Odetunde/Axios

  1. Global: Total confirmed cases as of 10 p.m. ET: 12,009,301 — Total deaths: 548,799 — Total recoveries — 6,561,969Map.
  2. U.S.: Total confirmed cases as of 10 p.m. ET: 3,053,328 — Total deaths: 132,256 — Total recoveries: 953,420 — Total tested: 37,532,612Map.
  3. Public health: Houston mayor cancels Republican convention over coronavirus concerns Deaths are rising in hotspots — Déjà vu sets in as testing issues rise and PPE dwindles.
  4. Travel: United warns employees it may furlough 45% of U.S. workforce How the pandemic changed mobility habits, by state.
  5. Education: New York City schools will not fully reopen in fallHarvard and MIT sue Trump administration over rule barring foreign students from online classes.
  6. 🎧 Podcast: A misinformation "infodemic" is here.

Transcripts show George Floyd told police "I can't breathe" over 20 times

Photo: Gary Coronado/Los Angeles Times via Getty Images

Newly released transcripts of bodycam footage from the Minneapolis Police Department show that George Floyd told officers he could not breathe more than 20 times in the moments leading up to his death.

Why it matters: Floyd's killing sparked a national wave of Black Lives Matter protests and an ongoing reckoning over systemic racism in the United States. The transcripts "offer one the most thorough and dramatic accounts" before Floyd's death, The New York Times writes.

5 hours ago - Health

Fighting the coronavirus infodemic

Illustration: Sarah Grillo/Axios

An "infodemic" of misinformation and disinformation has helped cripple the response to the novel coronavirus.

Why it matters: High-powered social media accelerates the spread of lies and political polarization that motivates people to believe them. Unless the public health sphere can effectively counter misinformation, not even an effective vaccine may be enough to end the pandemic.